[1] Zachou K, Muratori P, Koukoulis GK, et al.Autoimmune hepatitis- current management and challenges. Aliment Pharmacol Ther, 2013, 38:887-913. [2] Gleeson D, Heneghan MA. British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut, 2011, 60:1611-1629. [3] Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology, 2010, 139:58-72, e74. [4] Shen Y, Lu C, Men R, et al. Clinical and pathological characteristics of autoimmune hepatitis with acute presentation. Can J Gastroenterol Hepatol, 2018, 2018:3513206. [5] Ngu JH, BechlyK, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol, 2010, 25:1681-1686. [6] Mondul AM, Weinstein SJ, Layne TM, et al. Vitamin D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev, 2017, 39(1):28-48. [7] Skaaby T. The relationship of vitamin D status to risk of cardiovascular disease and mortality. Dan Med J, 2015, 62(2):B5008. [8] Ebadi M, Bhanji RA, Mazurak VC, et al. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. Aliment Pharmacol Ther, 2019, 49(2):173-182. [9] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 自身免疫性肝炎诊断和治疗共识(2015 年). 中华肝脏病杂志, 2016, 24(1):23-25. [10] 韦丽娅, 陈庆瑜, 甘小玲. 广州地区人群血清25 -羟维生素D水平的季节性变化. 中国全科医学, 2014, 17(35):4217-4219. [11] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪肝专家委员会. 非酒精性脂肪性肝病防治指南(2018年版). 实用肝脏病杂志, 2018, 21(2):177-186. [12] Liao R, Fu YP, Wang T, et al. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellularcarcinoma:a retrospective cohort study at two centers in China. Oncotarget, 2017, 8(1): 1774-1781. [13] Czaja AJ. Diagnosis and management of autoimmune hepatitis: current status and future directions. Gut Liver, 2016, 10(2):177-203. [14] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol, 2015, 63(4):971-1004. [15] Hübener S, Oo YH, Than NN, et al. Efficacy of 6-mercaptopurine as second-line treatment for patients with autoimmune hepatitis and azathioprine intolerance. Clin Gastroenterol Hepatol, 2016, 14(3):445-453. [16] Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, et al. Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int, 2010, 4:634-640. [17] Efe C, Kav T, Aydin C, et al. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci, 2014, 59:3035- 3042. [18] Duarte-Rey C, Pardo AL, Rodríguez-Velosa Y, et al. HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis. Autoimmun Rev, 2009, 8(4):325-331. [19] 范列英, 仲人前, 屠小卿, 等. 维生素D受体基因多态性与中国人自身免疫肝病相关性研究. 中华医学杂志, 2003, 83 (21):1852-1855. [20] 邹婷婷, 詹学. 儿童自身免疫性肝炎研究进展. 中华实用儿科临床杂志, 2016, 31(20): 1598-1600. |